BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37568209)

  • 1. Network analysis of neuropsychiatric symptoms in Alzheimer's disease.
    Goodwin GJ; Moeller S; Nguyen A; Cummings JL; John SE
    Alzheimers Res Ther; 2023 Aug; 15(1):135. PubMed ID: 37568209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network Analysis of Neuropsychiatric Symptoms in Alzheimer's Disease.
    Goodwin GJ; Moeller S; Nguyen A; Cummings JL; John SE
    Res Sq; 2023 Apr; ():. PubMed ID: 37163090
    [No Abstract]   [Full Text] [Related]  

  • 3. Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.
    Trzepacz PT; Saykin A; Yu P; Bhamditipati P; Sun J; Dennehy EB; Willis B; Cummings JL;
    Am J Geriatr Psychiatry; 2013 Jul; 21(7):607-22. PubMed ID: 23602309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining differences in neuropsychiatric symptom factor trajectories in empirically derived mild cognitive impairment subtypes.
    De Vito AN; Calamia M; Weitzner DS; Bernstein JPK;
    Int J Geriatr Psychiatry; 2018 Dec; 33(12):1627-1634. PubMed ID: 30276884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric Symptoms and the Diagnostic Stability of Mild Cognitive Impairment.
    Sugarman MA; Alosco ML; Tripodis Y; Steinberg EG; Stern RA
    J Alzheimers Dis; 2018; 62(4):1841-1855. PubMed ID: 29614641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between dementia staging, neuropsychiatric behavioral symptoms, and divorce or separation in late life: A case control study.
    Monin JK; McAvay G; Zang E; Vander Wyk B; Carrión CI; Allore H
    PLoS One; 2023; 18(8):e0289311. PubMed ID: 37585365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Exploration of Subgroups of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Risks of Conversion to Dementia or Death.
    Qiu J; Goldstein FC; Hanfelt JJ
    Am J Geriatr Psychiatry; 2022 Aug; 30(8):925-934. PubMed ID: 35067420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
    Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
    J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate.
    Ouanes S; Rabl M; Clark C; Kirschbaum C; Popp J
    Alzheimers Res Ther; 2022 Dec; 14(1):190. PubMed ID: 36529757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agitation in Cognitive Disorders: Use of the National Alzheimer's Coordinating Center Uniform Data Set (NACC-UDS) to Evaluate International Psychogeriatric Association Definition.
    Sano M; Zhu CW; Neugroschl J; Grossman HT; Schimming C; Aloysi A
    Am J Geriatr Psychiatry; 2022 Nov; 30(11):1198-1208. PubMed ID: 35562259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.
    Rosenberg PB; Mielke MM; Appleby BS; Oh ES; Geda YE; Lyketsos CG
    Am J Geriatr Psychiatry; 2013 Jul; 21(7):685-95. PubMed ID: 23567400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric assessment of Alzheimer's disease and related dementias.
    Cummings JL; McPherson S
    Aging (Milano); 2001 Jun; 13(3):240-6. PubMed ID: 11444257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Estimates from Real-World Data.
    Chandler J; Done N; Desai U; Georgieva M; Gomez-Lievano A; Ye W; Zhao A; Eid D; Hilts A; Kirson N; Schilling T
    J Prev Alzheimers Dis; 2024; 11(2):310-319. PubMed ID: 38374737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric features in a multi-ethnic population with Alzheimer disease and mild cognitive impairment.
    Celis K; Zaman A; Adams LD; Gardner O; Farid R; Starks TD; Lacroix FC; Hamilton-Nelson K; Mena P; Tejada S; Laux R; Song YE; Caban-Holt A; Feliciano-Astacio B; Vance JM; Haines JL; Byrd GS; Beecham GW; Pericak-Vance MA; Cuccaro ML
    Int J Geriatr Psychiatry; 2023 Sep; 38(9):e5992. PubMed ID: 37655494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the Link Between Cardiovascular Risk Factors and Neuropsychiatric Symptoms in Mild Cognitive Impairment and Major Depressive Disorder in Remission.
    Fischer CE; Kortebi I; Karameh WK; Kumar S; Gallagher D; Golas A; Munoz D; Barfett J; Butters MA; Bowie CR; Flint A; Rajji T; Herrmann N; Pollock BG; Mulsant B; Schweizer TA; Mah L;
    J Alzheimers Dis; 2019; 67(4):1305-1311. PubMed ID: 30741676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
    Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
    Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced quality-of-life ratings in mild cognitive impairment: analyses of subject and informant responses.
    Teng E; Tassniyom K; Lu PH
    Am J Geriatr Psychiatry; 2012 Dec; 20(12):1016-25. PubMed ID: 23018474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.